bimagrumab and tirzepatide Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines Can We Improve the Quality

Due to different mutations, patients with variants in the same gene may display a variety of phenotypes (allelic heterogeneity) [82]

GLP-1 therapies slow gastric emptying, which can delay the onset of edible cannabis effects and increase the risk that users take extra doses too soon, leading to stronger-than-expected highs

Robert Kushner, a co-investigator on SURMOUNT-1 and professor of medicine at Northwestern University Feinberg School of Medicine, has stated publicly that "the evidence base for most dietary supplements in obesity management is thin compared to what we now have for GLP-1 receptor agonists." That perspective applies directly to adding unproven supplements to a well-validated pharmacotherapy

Focus on nutrition: Find options that are higher in protein, fiber, or whole

Once your levels are restored, you might only need a maintenance shot every two or three months

Mechanistically, an in vitro study found that exendin-4 inhibited the secretion of IL-1 and TNF- from mouse colonic smooth muscle cells (CSMCs) via the pathway mediated by cAMP and NF-B, thereby exerting anti-inflammatory effects [218]